AstraZeneca
The Director of Diagnostics at AstraZeneca's Alexion division leads the strategic development, regulatory management, and external partnerships for diagnostics, focusing on precision medicine, biomarker validation, and assay development. The role involves building capabilities, processes, and collaborations to accelerate diagnostic innovation across clinical development and lifecycle management, particularly for rare diseases.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
Precision Medicine Global Biomarker Lead, Rare Disease
lifelancer
Global Director, Diagnostics and Scientific Affairs
sanofi us
Principal Scientist, Biomarker Assay Development Bench Scientist
Diversity Employment
Principal Scientist, Biomarker Assay Development Bench Scientist
Novartis
Precision Medicine Global Biomarker Lead , Rare Disease
Amgen
Principal Scientist, Biomarker Assay Development Bench Scientist
Novartis